Celladon appoints Michael Narachi as Chairman of the Board of Directors

– USA, CA – Celladon Corporation, a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, today announced that it has appointed Michael Narachi as Chairman of the Board of Directors.…